Evidence map›Paper›PMID 21795675›Full record

ArticleThe Journal of biological chemistry2011

Structure-function map of the receptor site for β-scorpion toxins in domain II of voltage-gated sodium channels.

Joel Z Zhang, Vladimir Yarov-Yarovoy, Todd Scheuer, Izhar Karbat, Lior Cohen, Dalia Gordon, Michael Gurevitz, William A Catterall

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Sodium channels and pain: from toxins to therapies.British journal of pharmacology · 2018
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Joel Z ZhangDepartment of Pharmacology, University of Washington, Seattle, Washington 98195-7280, USA.
Vladimir Yarov-Yarovoy
Todd Scheuer
Izhar Karbat
Lior Cohen
Dalia Gordon
Michael Gurevitz
William A Catterall

Funding

Receptor Sites and Antagonists for Paralytic NeurotoxinsU01NS058039 · NINDS · UNIVERSITY OF WASHINGTON · PI CATTERALL, WILLIAM A · 2006 to 2010
$3.1M
NINDS NIH HHS U01 NS058039
6 · The paper itself

Abstract

Voltage-gated sodium (Na(v)) channels are the molecular targets of β-scorpion toxins, which shift the voltage dependence of activation to more negative membrane potentials by a voltage sensor-trapping mechanism. Molecular determinants of β-scorpion toxin (CssIV) binding and action on rat brain sodium channels are located in the S1-S2 (IIS1-S2) and S3-S4 (IIS3-S4) extracellular linkers of the voltage-sensing module in domain II. In IIS1-S2, mutations of two amino acid residues (Glu(779) and Pro(782)) significantly altered the toxin effect by reducing binding affinity. In IIS3-S4, six positions surrounding the key binding determinant, Gly(845), define a hot spot of high-impact residues. Two of these substitutions (A841N and L846A) reduced voltage sensor trapping. The other three substitutions (N842R, V843A, and E844N) increased voltage sensor trapping. These bidirectional effects suggest that the IIS3-S4 loop plays a primary role in determining both toxin affinity and efficacy. A high resolution molecular model constructed with the Rosetta-Membrane modeling system reveals interactions of amino acid residues in sodium channels that are crucial for toxin action with residues in CssIV that are required for its effects. In this model, the wedge-shaped CssIV inserts between the IIS1-S2 and IIS3-S4 loops of the voltage sensor, placing key amino acid residues in position to interact with binding partners in these extracellular loops. These results provide new molecular insights into the voltage sensor-trapping model of toxin action and further define the molecular requirements for the development of antagonists that can prevent or reverse toxicity of scorpion toxins.

Indexed as

AnimalsIon Channel GatingModels, MolecularMutant ProteinsNAV1.2 Voltage-Gated Sodium ChannelNerve Tissue ProteinsProtein BindingProtein Structure, TertiaryRatsReceptors, Cell SurfaceScorpion VenomsSodium ChannelsStructure-Activity RelationshipMutant ProteinsNAV1.2 Voltage-Gated Sodium ChannelNerve Tissue ProteinsReceptors, Cell SurfaceScn2A protein, ratScorpion VenomsSodium Channels

Identifiers

PMID21795675
PMCPMC3190924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.